Automata Secures $40M for Lab Tech Growth
Automata Technologies, a leading player in the life science lab automation sector, has raised $40 million in funds. Dimension and A.P. Moller Holding support this impressive fundraising effort, signifying investors’ significant confidence in Automata’s vision and capabilities.
Vital Funds for Life Science Lab Automation Expansion
The funds obtained will be crucial in driving Automata’s expansion within the rapidly growing field of life science lab automation. This sector has gained substantial momentum, fueled by increasing demand for innovative solutions that enhance laboratory efficiency and productivity.
Automata Technologies has been at the forefront of this transformative industry, offering cutting-edge solutions that cater to the evolving needs of life science professionals. The company’s commitment to advancing lab automation has earned it recognition as a key player.
Automata’s LINQ automation platform aims to simplify automation adoption for science labs in research institutions, hospitals, pharmaceutical and biotech companies, and CROs. It caters to many workflows, whether they involve high-throughput processes or frequent changes requiring dynamic protocol development.
Mostafa Elsayed, Founder and CEO of Automata, said “The last two years have been hugely exciting at Automata as we’ve seen LINQ increase the scale of customer workflows as well as meaningfully increasing their ability to generate high quality data – accelerating their pace of discovery and experimentation.
Source: Automata
Advancing Lab Automation for Scientific Discovery
They aim to simplify complex lab tasks, enabling scientists to focus on discovery. This aligns with the industry trend of embracing automation for better research outcomes. As the life science sector evolves, Automata’s approach is crucial for labs aiming to stay research leaders.
This new funding round builds upon their previous $50 million Series B round from January 2022. That earlier funding enabled them to execute their commercialization and expansion plans, expanding in Europe and the UK and experiencing rapid US growth. Since January 2022, Automata has achieved remarkable milestones, including a 150% increase in revenue and a 12-fold increase in live system hours in customer-deployed systems.
Automata Technologies has achieved a significant milestone by raising $40 million, supported by Dimension and A.P. Moller Holding. This substantial investment positions Automata to enhance its life science lab automation solutions, playing a crucial role in shaping the future of laboratory research. It also underscores the increasing significance of automation in the life science industry, promising a bright future for Automata Technologies.
